dbuxton

Main Profile

Full Name and Degrees: 

Denis Buxton, Ph.D.

Member Role: 

NHLBI Representative

More Info: 

National Heart, Lung, and Blood Institute Photos and Bios

Institutional affiliation: 

NHLBI, National Institutes of Health

Biography: 

Dr. Denis Buxton is Associate Director of the Basic and Early Translational Research Program in the Division of Cardiovascular Diseases at the National Heart Lung and Blood Institute (NHLBI). He received his bachelor’s degree from University College London in biochemistry (1977) and continued on to receive his Ph.D. from the same institution in Biochemistry (1980).

Dr. Buxton joined NHLBI as a senior fellow in 1996. He was appointed Assistant Director of the Heart Research Program in NHLBI's Division of Heart and Vascular Diseases in 2001. In 2005, he was appointed Acting Director of the Heart Research Program. A year later, he became Chief of the Advanced Technologies and Surgery Branch.

Dr. Buxton is the author or coauthor of 70+ papers, book chapters, letters, and review articles. He is a Consulting Editor for Cardiovascular Research, and reviewer for several medical journals, including:

Circulation
Lancet
American Journal of Physiology
Journal of Biological Chemistry
Nanomedicine

Additional links: 

• [[http://nihroadmap.nih.gov/nanomedicine/biographies/buxton.asp|Biography Page]]
• [[http://en.scientificcommons.org/denis_b_buxton|List of Publications]]

Research hub: 

NHLBI

Hub Site: 

None

research focus: 

Dr. Buxton's work focuses on molecular imaging, nanotechnology, myocardial ischemia and reperfusion and cell transplantation.

Recent publications: 

Current status of nanotechnology approaches for cardiovascular disease: a personal perspective. Buxton DB. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009; 1(2):149-155. [[http://wires.wiley.com/WileyCDA/WiresArticle/wisId-WNAN8.html|Abstract]]Nanomedicine for the management of lung and blood diseases. Buxton DB. Nanomedicine 2009; 4(3):331-339. [[http://www.futuremedicine.com/doi/abs/10.2217/nnm.09.8|Abstract]]Nanotechnology in the diagnosis and management of heart, lung and blood diseases. Buxton DB. Expert Rev Mol Diagn 2007; 7(2):149-160. [[http://www.ingentaconnect.com/content/ftd/erm/2007/00000007/00000002/art00006|Abstract]]The promise of nanotechnology for heart, lung and blood diseases. Buxton D. Expert Opin Drug Deliv 2006; 3(2):173-175. [[http://informahealthcare.com/doi/abs/10.1517/17425247.3.2.173|Abstract]]Cytokines and late preconditioning. Buxton DB. Cardiovasc Res 2004 1; 64(1):6-8. [[http://cardiovascres.oxfordjournals.org/content/64/1/6.full|Abstract]]

Address: 

National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health, 6701 Rockledge Drive, Room 8216, Bethesda, MD 20892

Phone: 

(301) 435-0513

People: 

cell transplantation

molecular imaging

myocardial ischemia

nanotechnology

reperfusion

Profile Page Photo: